Showing results (41-50 of 49) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
American Journal of Nephrology|November 21, 2022
Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor DanicopanSteven D Podos, Howard Trachtman, Gerald B Appel, et al.American Journal of Nephrology|November 24, 2022
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 StudiesCarla Nester, Gerald B Appel, Andrew S Bomback, et al.Kidney International|August 22, 2024
An expert discussion on the atypical hemolytic uremic syndrome nomenclature-identifying a road map to precision: a report of a National Kidney Foundation Working GroupCarla M Nester, David L Feldman, Richard Burwick, et al.Arthritis & Rheumatology (Hoboken, N.J.)|August 6, 2020
Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus NephritisYemil Atisha-Fregoso, Susan Malkiel, Kristina M Harris, et al.Nature Communications|August 27, 2024
Plasma proteomics of acute tubular injuryInsa M Schmidt, Aditya L Surapaneni, Runqi Zhao, et al.Biorxiv : the Preprint Server for Biology|June 19, 2023
The chromatin landscape of healthy and injured cell types in the human kidneyDebora L Gisch, Michelle Brennan, Blue B Lake, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 27, 2021
Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney FoundationAndrew S Bomback, Gerald B Appel, Debbie S Gipson, et al.The New England Journal of Medicine|July 4, 2019
Rituximab or Cyclosporine in the Treatment of Membranous NephropathyFernando C Fervenza, Gerald B Appel, Sean J Barbour, et al.Nature Communications|January 10, 2024
The chromatin landscape of healthy and injured cell types in the human kidneyDebora L Gisch, Michelle Brennan, Blue B Lake, et al.Pageof 5